Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 13, Issue 1, 2009, Pages 44-53

  Bobryshev, Yuri V ^a   Tran, Dinh ^b   Killingsworth, Murray C ^c   Buckland, Michael ^b   Lord, Reginald V N ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

Author keywords

Barrett's esophagus; CD83; Dendritic cells; Esophageal neoplasms; Inflammation; Intestinal metaplasia

Indexed keywords

CD83 ANTIGEN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; CELLULAR IMMUNITY; COMPARATIVE STUDY; DENDRITIC CELL; ELECTRON MICROSCOPY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROGNOSIS; ULTRASTRUCTURE;

ADENOCARCINOMA; ANTIGENS, CD; BARRETT ESOPHAGUS; BIOPSY; DENDRITIC CELLS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; PROGNOSIS;

EID: 57849160620     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-008-0613-9     Document Type: Article

References (57)

1. J Lagergren R Bergstrom A Lindgren O Nyren 1999 Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 825 831
2. RV Lord 2001 Genetic basis of the Barrett's metaplasia, dysplasia, adenocarcinoma sequence Probl Gen Surg 18 53 70
3. M Kerkhof JG Kusters H van Dekken EJ Kuipers PD Siersema 2007 Biomarkers for risk stratification of neoplastic progression in Barrett esophagus Cell Oncol 29 507 517
4. JM Quinlan BJ Colleypriest M Farrant D Tosh 2007 Epithelial metaplasia and the development of cancer Biochim Biophys Acta 1776 10 21
5. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66
6. BJ Kendall DC Whiteman 2006 Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region Am J Gastroenterol 101 1178 1182
7. J Lagergren R Bergstrom O Nyren 1999 Association between body mass and adenocarcinoma of the esophagus and gastric cardia Ann Intern Med 130 883 890
8. DC Whiteman S Sadeghi N Pandeya 2008 Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus Gut 57 173 180
9. H Pohl HG Welch 2005 The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 142 146
10. RV Lord MG Law RL Ward GG Giles RJ Thomas V Thursfield 1998 Rising incidence of oesophageal adenocarcinoma in men in Australia J0 Gastroenterol Hepatol 13 356 362
11. M Solaymani-Dodaran RF Logan J West T Card C Coupland 2004 Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Gut 53 1070 1074
12. KJ O'Byrne AG Dalgleish 2001 Chronic immune activation and inflammation as the cause of malignancy Br J Cancer 85 473 483
13. AG Dalgleish KJ O'Byrne 2002 Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer Adv Cancer Res 84 231 276
14. M Macarthur GL Hold EM El-Omar 2004 Inflammation and cancer II role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy Am J Physiol Gastrointest Liver Physiol 286 G515 G520
15. JW Hadden 2003 Immunodeficiency and cancer: prospects for correction Int Immunopharmacol 3 1061 1071
16. LM Moons JG Kusters E Bultman 2005 Barrett's oesophagus is characterized by a predominantly humoral inflammatory response J Pathol 207 269 276
17. SJ Cronin JM Penninger 2007 From T-cell activation signals to signaling control of anti-cancer immunity Immunol Rev 220 151 168
18. J Banchereau RM Steinman 1998 Dendritic cells and control of immunity Nature 392 245 252
19. Lotze MT, Thomson AW. Dendritic Cells: Biology and Clinical Applications. 2nd ed. San Diego, CA: Academic, 2001.
20. MF Lipscomb BJ Masten 2002 Dendritic cells: immune regulators in health and disease Physiol Rev 82 97 130
21. RM Steinman D Hawiger MC Nussenzweig 2003 Tolerogenic dendritic cells Annu Rev Immunol 21 685 711
22. WR Heath GT Belz GM Behrens 2004 Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens Immunol Rev 199 9 26
23. EC de Jong HH Smits ML Kapsenberg 2005 Dendritic cell-mediated T cell polarization Springer Semin Immunopathol 26 289 307
24. RM Steinman J Banchereau 2007 Taking dendritic cells into medicine Nature 449 419 426
25. RM Steinman ZA Cohn 1973 Identification of a novel cell type in peripheral lymphoid organs of mice: I. Morphology, quantification, tissue distribution J Exp Med 137 1142 1162
26. AR Dadabayev MH Sandel AG Menon 2004 Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells Cancer Immunol Immunother 53 978 986
27. MJ Alavaikko G Blanco R Aine 1994 Follicular dendritic cells have prognostic relevance in Hodgkins disease Am J Clin Pathol 101 761 767
28. K Ambe M Mori M Enjoji 1989 S-100 protein-positive dendritic cells in colorectal adenocarcinomas: distribution and relation to the clinical prognosis Cancer 63 496 503
29. PB Bethwaite LJ Holloway A Thornton B Delahunt 1996 Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study Pathology 28 321 327
30. M Furihata Y Ohtsuki E Ido 1992 HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma-their distribution in relation to prognosis Virchows Arch B Cell Pathol Incl Mol Pathol 61 409 414
31. A Giannini S Bianchi L Messerini 1991 Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma Pathol Res Pract 187 496 502
32. K Inoue M Furihata Y Ohtsuki Y Fujita 1993 Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis Virchows Arch A Pathol Anat Histopathol 422 351 355
33. S Ishigami S Natsugoe K Tokuda 2000 Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer Cancer Lett 159 103 108
34. M Mori K Ambe Y Adachi 1988 Prognostic value of immunohistochemically identified CEA, SC, AFP, and S-100 protein-positive cells in gastric carcinoma Cancer 62 534 540
35. TE Reichert C Scheuer R Day W Wagner TL Whiteside 2001 The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma Cancer 91 2136 2147
36. S Berchtold P Mühl-Zürbes E Maczek A Golka G Schuler A Steinkasserer 2002 Cloning and characterization of the promoter region of the human CD83 gene Immunobiology 205 231 246
37. M Lechmann E Zinser A Golka A Steinkasserer 2002 Role of CD83 in the immunomodulation of dendritic cells Int Arch Allergy Immunol 129 113 118
38. M Breloer B Kretschmer K Lüthje 2007 CD83 is a regulator of murine B cell function in vivo Eur J Immunol 37 634 648
39. Y Fujimoto L Tu AS Miller 2002 CD83 expression influences CD4+ T cell development in the thymus Cell 108 755 767
40. M Lechmann DJ Krooshoop D Dudziak 2001 The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells J Exp Med 194 1813 1821
41. YV Bobryshev RS Lord 1998 Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions Cardiovasc Res 37 799 810
42. YV Bobryshev RSA Lord 1995 Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta Arch Histol Cytol 58 307 322
43. F Milano AM Rygiel N Buttar 2007 An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer Cancer Immunol Immunother 56 1967 1977
44. Abbas AK, Lichtman AH. Immunity to tumor. In Abbas AK, Lichtman AH, eds. Cellular and molecular immunology, 5th ed. USA: Saunders, 2003, pp 391-410.
45. TF Greten EM Jaffee 1999 Cancer vaccines J Clin Oncol 17 1047 1060
46. D Gabrilovich 2004 Mechanisms and functional significance of tumor-induced dendritic-cell defects Nat Rev Immunol 4 941 952
47. S Byrne GM Halliday 2002 Dendritic cells: making progress with tumour regression? Immunol Cell Biol 80 520 530
48. M Furihata Y Ohtsuki H Sonobe 1993 Prognostic significance of simultaneous infiltration of HLA-DRpositive dendritic cells and tumor infiltrating lymphocytes into human esophageal carcinoma Tohoku J Exp Med 169 187 195
49. W Yang J Yu 2008 Immunologic function of dendritic cells in esophageal cancer Dig Dis Sci 53 1739 1746
50. E Ido M Furihata Y Ohtsuki J Iwata H Sonobe 1994 S-100 protein positive dendritic cells detected in hepatocellular carcinoma in relation to tumor progression and prognosis Int J Oncol 5 231 236
51. M Thurnher C Radmayr R Ramoner 1996 Human renal-cell carcinoma tissue contains dendritic cells Int J Cancer 68 1 7
52. AJ Troy KL Summers PJ Davidson CH Atkinson DN Hart 1998 Minimal recruitment and activation of dendritic cells within renal cell carcinoma Clin Cancer Res 4 585 593
53. RB Mailliard RM Dallal YI Son MT Lotze 2000 Dendritic cells promote T-cell survival or death depending upon their maturation state and presentation of antigen Immunol Invest 29 177 185
54. DI Gabrilovich J Corak IF Ciernik D Kavanaugh DP Carbone 1997 Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 3 483 490
55. B Almand JR Resser B Lindman 2000 Clinical significance of defective dendritic cell differentiation in cancer Clin Cancer Res 6 1755 1766
56. K Takahashi M Naito LD Shultz S Hayashi S Nishikawa 1993 Differentiation of dendritic cell populations in macrophage colony-stimulating factor-deficient mice homozygous for the osteopetrosis (op) mutation J Leukoc Biol 53 19 28
57. MA Markiewicz WM Kast 2004 Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes Cancer Invest 22 417 434